KD Logo

Insider Selling Buzz: Macrogenics Inc [MGNX] Senior VP and General Counsel Peters Jeffrey Stuart sold 51,395 shares of the company

Macrogenics Inc’s recently made public that its Senior VP and General Counsel Peters Jeffrey Stuart unloaded Company’s shares for reported $0.8 million on Apr 04 ’24. In the deal valued at $15.55 per share,51,395 shares were sold. As a result of this transaction, Peters Jeffrey Stuart now holds 0 shares worth roughly $0.0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Peters Jeffrey Stuart sold 19,625 shares, generating $421,938 in total proceeds. Upon selling the shares at $21.50, the Senior VP and General Counsel now owns 8,895 shares.

Before that, Risser Eric Blasius sold 41,159 shares. Macrogenics Inc shares valued at $813,501 were divested by the Chief Operating Officer at a price of $19.76 per share. As a result of the transaction, Risser Eric Blasius now holds 38,900 shares, worth roughly $0.17 million.

TD Cowen downgraded its Macrogenics Inc [MGNX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in early May from “a Buy” to “a Hold”. BMO Capital Markets also remained covering MGNX and has decreased its forecast on May 10, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. B. Riley Securities started covering the stock on April 26, 2024. It rated MGNX as “a Buy”.

Price Performance Review of MGNX

On Monday, Macrogenics Inc [NASDAQ:MGNX] saw its stock jump 32.33% to $4.38. Over the last five days, the stock has lost -73.24%. Macrogenics Inc shares have fallen nearly -54.47% since the year began. Nevertheless, the stocks have fallen -36.24% over the past one year. While a 52-week high of $21.88 was reached on 03/06/24, a 52-week low of $3.14 was recorded on 05/10/24. SMA at 50 days reached $15.79, while 200 days put it at $10.26. A total of 19.46 million shares were traded, compared to the trading of 35.15 million shares in the previous session.

Levels Of Support And Resistance For MGNX Stock

The 24-hour chart illustrates a support level at 3.70, which if violated will result in even more drops to 3.03. On the upside, there is a resistance level at 4.75. A further resistance level may holdings at 5.13. The Relative Strength Index (RSI) on the 14-day chart is 21.16, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.70%. Stochastics %K at 14.65% indicates the stock is a buying.

Most Popular